E-LIB Suche - Ergebnisse für: Paz‐Ares, Luis

1

Targeted therapy for lung cancer: Beyond EGFR and ALK:

Herrera‐Juárez, Mercedes ; Serrano‐Gómez, Cristina ; Bote‐de‐Cabo, Helena.
Cancer. 129 (2023) 12 - p. 1803-1820 , 2023

Link: https://doi.org/10.1002/..

2

RESILIENT part 1: a phase 2 dose‐exploration and dose‐expan..:

Paz‐Ares, Luis ; Spigel, David R. ; Chen, Yuanbin...
Cancer. 128 (2022) 9 - p. 1801-1811 , 2022

Link: https://doi.org/10.1002/..

3

LungBEAM: A prospective multicenter study to monitor stage ..:

Garrido, Pilar ; Paz‐Ares, Luis ; Majem, Margarita...
Cancer Medicine. 10 (2021) 17 - p. 5878-5888 , 2021

Link: https://doi.org/10.1002/..

4

Pembrolizumab plus chemotherapy versus chemotherapy alone i..:

Borghaei, Hossein ; Langer, Corey J. ; Paz‐Ares, Luis...
Cancer. 126 (2020) 22 - p. 4867-4877 , 2020

Link: https://doi.org/10.1002/..

5

Aligning digital CD8+ scoring and targeted next‐generation ..:

Conde, Esther ; Caminoa, Alejandra ; Dominguez, Carolina...
Histopathology. 72 (2017) 2 - p. 270-284 , 2017

Link: https://doi.org/10.1111/..

6

Pooled analysis of clinical outcome for EGFR TKI‐treated pa..:

Paz‐Ares, Luis ; Soulières, Denis ; Moecks, Joachim...
Journal of Cellular and Molecular Medicine. 18 (2014) 8 - p. 1519-1539 , 2014

Link: https://doi.org/10.1111/..

7

Down‐regulation of spinophilin in lung tumours contributes ..:

Molina‐Pinelo, Sonia ; Ferrer, Irene ; Blanco‐Aparicio, Carmen...
The Journal of Pathology. 225 (2011) 1 - p. 73-82 , 2011

Link: https://doi.org/10.1002/..

8

Clinical outcomes in non‐small‐cell lung cancer patients wi..:

Paz‐Ares, Luis ; Soulières, Denis ; Melezínek, Ivan...
Journal of Cellular and Molecular Medicine. 14 (2010) 1-2 - p. 51-69 , 2010

Link: https://doi.org/10.1111/..

9

Assessment of procalcitonin as a diagnostic and prognostic ..:

Jimeno, Antonio ; García‐Velasco, Adelaida ; del Val, Olga...
Cancer. 100 (2004) 11 - p. 2462-2469 , 2004

Link: https://doi.org/10.1002/..

10

Pretreatment prognostic factors for survival in patients wi..:

Bellmunt, Joaquim ; Albanell, Joan ; Paz‐Ares, Luis...
Cancer. 95 (2002) 4 - p. 751-757 , 2002

Link: https://doi.org/10.1002/..

11

Molecular classification and biomarkers of outcome with imm..:

Xie, Mingchao ; Vuko, Miljenka ; Rodriguez-Canales, Jaime...
Molecular Cancer. 23 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

12

Safety of pembrolizumab as adjuvant therapy in a pooled ana..:

Luke, Jason J. ; Long, Georgina V. ; Robert, Caroline...
European Journal of Cancer. 207 (2024) - p. 114146 , 2024

Link: https://doi.org/10.1016/..

13

Sotorasib in KRASG12C mutated lung cancer – Authors' reply:

Paz-Ares, Luis ; Mehta, Bhakti ; Wang, Yang...
The Lancet. 403 (2024) 10422 - p. 145-146 , 2024

Link: https://doi.org/10.1016/..

14

CEA-CD3 bispecific antibody cibisatamab with or without ate..:

Segal, Neil H. ; Melero, Ignacio ; Moreno, Victor...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

15

Lurbinectedin in patients with small cell lung cancer with ..:

Peters, Solange ; Trigo, José ; Besse, Benjamin...
Lung Cancer. 188 (2024) - p. 107448 , 2024

Link: https://doi.org/10.1016/..